CoronaVac and ChAdOx1 Vaccination and Gamma Infection Elicited Neutralizing Antibodies against the SARS-CoV-2 Delta Variant

The emergence of new SARS-CoV-2 variants represents a constant threat to world public health. The SARS-CoV-2 Delta variant was identified in late 2020 in India; since then, it has spread to many other countries, replacing other predominant lineages and raising concerns about vaccination efficiency....

Descripción completa

Detalles Bibliográficos
Autores principales: Fumagalli, Marcilio Jorge, Castro-Jorge, Luiza Antunes, de Souza, William Marciel, de Azevedo, Patrick Orestes, Hansen, Alana Witt, Gazzinelli, Ricardo Tostes, da Fonseca, Benedito Antônio Lopes, Spilki, Fernando Rosado, Figueiredo, Luiz Tadeu Moraes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880081/
https://www.ncbi.nlm.nih.gov/pubmed/35215895
http://dx.doi.org/10.3390/v14020305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880081/
https://www.ncbi.nlm.nih.gov/pubmed/35215895
http://dx.doi.org/10.3390/v14020305

Ejemplares similares